Novavax: Deal agreed to 'fill and fini - 股票

原文標題：Novavax: Deal agreed to 'fill and finish' 60 million doses in UK

原文連結：https://www.bbc.com/news/uk-england-tees-56570168

發布時間：2021/03/29

原文內容：

Tens of millions of doses of the Novavax vaccine will now be produced and packaged in the North East, the prime minister has announced.

Boris Johnson said a deal had been agreed with GlaxoSmithKline (GSK) to bottle 60 million doses at its facility in Barnard Castle.

GSK said it hoped the "fill and finish" process can begin as early as May.

In January, it was announced the vaccine would be manufactured at the Fujifilm plant in Stockton-on-Tees.

Novavax is currently being assessed by the Medicines and Healthcare products Regulatory Agency.

The biotech company behind it, also called Novavax, recently announced its vaccine was 86% effective against the Kent variant of Covid-19 and 96% effective in preventing cases caused by the original strain.

Mr Johnson said: "I'm delighted by GSK's investment, which shows the strength of UK manufacturing, and will further boost our vaccine rollout.

"The Vaccines Taskforce has worked hand in glove with business to successfully deliver vaccines to the whole of the UK, and this agreement will continue to support our approach.

"We remain on track to offer a first jab to all over 50s by 15 April, and all adults by the end of July, and I want to once again encourage everyone to come forward for a vaccine when you're called."

簡單重點：：

鮑里斯·約翰遜(Boris Johnson)揭幕了新的英國疫苗工廠：政府與製藥巨頭葛蘭素史克(GlaxoSmithKline)簽署協議，將在達勒姆“補充和完成”6,000萬劑諾瓦瓦克斯(Novavax )的新冠病毒疫苗，這將成為第五種獲得批准的疫苗。

英國已經與美國公司簽訂了一項預先購買協議，購買了6,000萬劑Novavax兩針疫苗，足以讓3,000萬英國人完全接種。本月早些時候，諾瓦瓦克斯(Novavax)宣布，其疫苗在阻止症狀性疾病方面的有效性為89%，並100%阻止了住院和死亡。

諾瓦瓦克斯將於未來幾周向英國醫療監管機構提交晚期試驗數據，預計將於5月獲得批准。迄今為止，已經有三種疫苗被MHRA批准，分別由輝瑞、阿斯利康和Moderna生產，而由強生研發的第四種疫苗目前正在審查中。

心得/評論：

除了上面利好消息，

印度血清研究所稱，與美國製藥巨頭Novavax聯合開發的Covovax疫苗整體有效率為89%。

目前NOVAVAX疫苗未來趨勢看漲。



--